In this video, Arshad Khanani, MD, speaks about a post hoc comparative assessment of patients treated with brolucizumab vs. aflibercept in the HAWK and HARRIER phase 3 studies.
For his presentation on this topic, Khanani received the best free paper award at the virtual Euretina congress.